Industry: Food & Beverages
Published Date: 2025-03-05
Pages: 80 Pages
Report ld: 4408388
Request Sample
Customized Report
Zymosan Market Size(US$)

CAGR 2025-2031
2.8%
Market Size,2031
USD 168
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Zymosan market size was US$ 138 million in 2024 and is forecast to a readjusted size of US$ 168 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Zymosan is a type of functional polysaccharide extracted from yeast cell wall, mainly including β-glucan and mannan oligosaccharide. They have various biological activities such as immunomodulation, antioxidant, and promotion of intestinal health. Yeast polysaccharide cannot form a true solution in water, but can only form a colloid. It has no reducing properties and mutarotation properties, but has optical rotation.
The North America Zymosan market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Zymosan include Lesaffre, Lallemand, AB Mauri, DSM, Biorigin, Ohly, Angel Yeast, Zhuhai TXY Biotech, Yinqi Biological Technology, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Zymosan market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Zymosan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Zymosan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Zymosan manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Zymosan revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Zymosan Product Scope
1.2 Zymosan by Type
1.2.1 Global Zymosan Sales by Type (2020 & 2024 & 2031)
1.2.2 Chemical Extraction
1.2.3 Enzymatic Extraction
1.3 Zymosan by Application
1.3.1 Global Zymosan Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Food
1.3.3 Medicine
1.3.4 Feed
1.3.5 Other
1.4 Global Zymosan Market Estimates and Forecasts (2020-2031)
1.4.1 Global Zymosan Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Zymosan Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Zymosan Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Zymosan Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Zymosan Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Zymosan Sales Market Share by Region (2020-2025)
2.2.2 Global Zymosan Revenue Market Share by Region (2020-2025)
2.3 Global Zymosan Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Zymosan Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Zymosan Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Zymosan Market Size and Prospective (2020-2031)
2.4.2 Europe Zymosan Market Size and Prospective (2020-2031)
2.4.3 China Zymosan Market Size and Prospective (2020-2031)
2.4.4 Japan Zymosan Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Zymosan Historic Market Review by Type (2020-2025)
3.1.1 Global Zymosan Sales by Type (2020-2025)
3.1.2 Global Zymosan Revenue by Type (2020-2025)
3.1.3 Global Zymosan Price by Type (2020-2025)
3.2 Global Zymosan Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Zymosan Sales Forecast by Type (2026-2031)
3.2.2 Global Zymosan Revenue Forecast by Type (2026-2031)
3.2.3 Global Zymosan Price Forecast by Type (2026-2031)
3.3 Different Types Zymosan Representative Players
4 Global Market Size by Application
4.1 Global Zymosan Historic Market Review by Application (2020-2025)
4.1.1 Global Zymosan Sales by Application (2020-2025)
4.1.2 Global Zymosan Revenue by Application (2020-2025)
4.1.3 Global Zymosan Price by Application (2020-2025)
4.2 Global Zymosan Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Zymosan Sales Forecast by Application (2026-2031)
4.2.2 Global Zymosan Revenue Forecast by Application (2026-2031)
4.2.3 Global Zymosan Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Zymosan Application
5 Competition Landscape by Players
5.1 Global Zymosan Sales by Players (2020-2025)
5.2 Global Top Zymosan Players by Revenue (2020-2025)
5.3 Global Zymosan Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zymosan as of 2024)
5.4 Global Zymosan Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Zymosan, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Zymosan, Product Type & Application
5.7 Global Key Manufacturers of Zymosan, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Zymosan Sales by Company
6.1.1.1 North America Zymosan Sales by Company (2020-2025)
6.1.1.2 North America Zymosan Revenue by Company (2020-2025)
6.1.2 North America Zymosan Sales Breakdown by Type (2020-2025)
6.1.3 North America Zymosan Sales Breakdown by Application (2020-2025)
6.1.4 North America Zymosan Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Zymosan Sales by Company
6.2.1.1 Europe Zymosan Sales by Company (2020-2025)
6.2.1.2 Europe Zymosan Revenue by Company (2020-2025)
6.2.2 Europe Zymosan Sales Breakdown by Type (2020-2025)
6.2.3 Europe Zymosan Sales Breakdown by Application (2020-2025)
6.2.4 Europe Zymosan Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Zymosan Sales by Company
6.3.1.1 China Zymosan Sales by Company (2020-2025)
6.3.1.2 China Zymosan Revenue by Company (2020-2025)
6.3.2 China Zymosan Sales Breakdown by Type (2020-2025)
6.3.3 China Zymosan Sales Breakdown by Application (2020-2025)
6.3.4 China Zymosan Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Zymosan Sales by Company
6.4.1.1 Japan Zymosan Sales by Company (2020-2025)
6.4.1.2 Japan Zymosan Revenue by Company (2020-2025)
6.4.2 Japan Zymosan Sales Breakdown by Type (2020-2025)
6.4.3 Japan Zymosan Sales Breakdown by Application (2020-2025)
6.4.4 Japan Zymosan Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Lesaffre
7.1.1 Lesaffre Company Information
7.1.2 Lesaffre Business Overview
7.1.3 Lesaffre Zymosan Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Lesaffre Zymosan Products Offered
7.1.5 Lesaffre Recent Development
7.2 Lallemand
7.2.1 Lallemand Company Information
7.2.2 Lallemand Business Overview
7.2.3 Lallemand Zymosan Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Lallemand Zymosan Products Offered
7.2.5 Lallemand Recent Development
7.3 AB Mauri
7.3.1 AB Mauri Company Information
7.3.2 AB Mauri Business Overview
7.3.3 AB Mauri Zymosan Sales, Revenue and Gross Margin (2020-2025)
7.3.4 AB Mauri Zymosan Products Offered
7.3.5 AB Mauri Recent Development
7.4 DSM
7.4.1 DSM Company Information
7.4.2 DSM Business Overview
7.4.3 DSM Zymosan Sales, Revenue and Gross Margin (2020-2025)
7.4.4 DSM Zymosan Products Offered
7.4.5 DSM Recent Development
7.5 Biorigin
7.5.1 Biorigin Company Information
7.5.2 Biorigin Business Overview
7.5.3 Biorigin Zymosan Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Biorigin Zymosan Products Offered
7.5.5 Biorigin Recent Development
7.6 Ohly
7.6.1 Ohly Company Information
7.6.2 Ohly Business Overview
7.6.3 Ohly Zymosan Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Ohly Zymosan Products Offered
7.6.5 Ohly Recent Development
7.7 Angel Yeast
7.7.1 Angel Yeast Company Information
7.7.2 Angel Yeast Business Overview
7.7.3 Angel Yeast Zymosan Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Angel Yeast Zymosan Products Offered
7.7.5 Angel Yeast Recent Development
7.8 Zhuhai TXY Biotech
7.8.1 Zhuhai TXY Biotech Company Information
7.8.2 Zhuhai TXY Biotech Business Overview
7.8.3 Zhuhai TXY Biotech Zymosan Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Zhuhai TXY Biotech Zymosan Products Offered
7.8.5 Zhuhai TXY Biotech Recent Development
7.9 Yinqi Biological Technology
7.9.1 Yinqi Biological Technology Company Information
7.9.2 Yinqi Biological Technology Business Overview
7.9.3 Yinqi Biological Technology Zymosan Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Yinqi Biological Technology Zymosan Products Offered
7.9.5 Yinqi Biological Technology Recent Development
8 Zymosan Manufacturing Cost Analysis
8.1 Zymosan Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Zymosan
8.4 Zymosan Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Zymosan Distributors List
9.3 Zymosan Customers
10 Zymosan Market Dynamics
10.1 Zymosan Industry Trends
10.2 Zymosan Market Drivers
10.3 Zymosan Market Challenges
10.4 Zymosan Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Zymosan market is projected to grow from US$ 143 million in 2025 to US$ 173 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 141
USD 4900.00
(Single User License)
The global Zymosan market size was US$ 143 million in 2025 and is forecast to reach a readjusted size of US$ 173 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 80
USD 4250.00
(Single User License)
The global Zymosan market was valued at US$ 143 million in 2025 and is anticipated to reach US$ 173 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 113
USD 2900.00
(Single User License)
The global market for Zymosan was estimated to be worth US$ 143 million in 2025 and is projected to reach US$ 173 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 94
USD 3950.00
(Single User License)
The global market for Zymosan was estimated to be worth US$ 138 million in 2024 and is forecast to a readjusted size of US$ 168 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-03-06
Pages: 98
USD 3950.00
(Single User License)
Valued at US$ 143 million in 2024, the global Zymosan market is forecast to reach US$ 168 million by 2030, at a CAGR of 2.8% during the forecast period.
Published Date: 2025-03-05
Pages: 144
USD 4900.00
(Single User License)
The global market for Zymosan was valued at US$ 138 million in the year 2024 and is projected to reach a revised size of US$ 168 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published Date: 2025-03-05
Pages: 86
USD 2900.00
(Single User License)
The global Zymosan market is projected to grow from US$ 143 million in 2025 to US$ 173 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 141
The global Zymosan market size was US$ 143 million in 2025 and is forecast to reach a readjusted size of US$ 173 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 80
The global Zymosan market was valued at US$ 143 million in 2025 and is anticipated to reach US$ 173 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-03-11
Pages: 113
The global market for Zymosan was estimated to be worth US$ 143 million in 2025 and is projected to reach US$ 173 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-03-08
Pages: 94
The global market for Zymosan was estimated to be worth US$ 138 million in 2024 and is forecast to a readjusted size of US$ 168 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-03-06
Pages: 98
Valued at US$ 143 million in 2024, the global Zymosan market is forecast to reach US$ 168 million by 2030, at a CAGR of 2.8% during the forecast period.
Published: 2025-03-05
Pages: 144
The global market for Zymosan was valued at US$ 138 million in the year 2024 and is projected to reach a revised size of US$ 168 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published: 2025-03-05
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now